Get the latest long-term care news with our monthly Quality Digest newsletter.
View in browser
PMC QD headers 2024 oct
PMC clinical news 2024 blue

Clinical Advisory: 2024-2025 COVID-19 Vaccine Update

On August 22, 2024, the FDA approved and authorized updated 2024-25 mRNA COVID-19 vaccines to better protect against currently circulating variants. The updated vaccines include Spikevax (Moderna) and Comirnaty (Pfizer), fully FDA-approved for individuals 12 years and older, and the Moderna and Pfizer-BioNTech COVID-19 vaccines, authorized for emergency use for individuals ages 6 months through 11 years old. On August 30, 2024, the FDA additionally granted emergency use authorization for the updated 2024-2025 Novavax COVD-19 vaccine for individuals ages 12 years and older.

LEARN MORE >

Onco360® Has Been Selected as a National Specialty Pharmacy for VORANIGO® (vorasidenib)

Onco360® has been selected by Servier Pharmaceuticals as a specialty pharmacy partner for VORANIGO® (vorasidenib), which is approved for the treatment of adults and pediatric patients 12 years and older with grade 2 astrocytoma or oligodendroglioma and a susceptible isocitrate dehydrogenase-1 (IDH1) or isocitrate dehydrogenase-2 (IDH2) mutation following surgery including biopsy, sub-total resection, or gross total resection.

LEARN MORE >
PMC reg updates 2024 grey-1

Compliance Cue: Guidance for Pharmacy-Related Updates to MDS 3.0 

This Compliance Cue covers important pharmacy-related updates to sections N and O of the MDS 3.0 version 1.19.1, effective October 1, 2024.

LEARN MORE >

Guide to Managing Payment & Regulatory Risk: MDS 1.19.1 

The balancing act of managing payments and regulatory risk requires flexibility, agility, and planning. This new guide, written in partnership with Leah Klusch of The Alliance Training Center, offers insights, tips, and updates to help you meet the challenges and take advantage of the opportunities. 

LEARN MORE >

Medicaid Access Rule: What I/DD Providers Need to Know 

This article answers five key questions about the Ensuring Access to Medicaid Services rule, including its meaning, requirements, and potential impact on I/DD providers. 

LEARN MORE >
PMC upcoming events 2024 orange-1
PharMerica Illuminate header
October 22 med optimization

A Collaborative Approach to Medication Optimization

Tuesday, October 22

1pm ET

REGISTER >
infection prevention webinar Oct 2024

Infection Prevention: Back to Basics

Tuesday, October 29

1pm ET

REGISTER >
SUD mental illness webinar

Co-Occurring Substance Use Disorder & Mental Illness

Tuesday, November 12

1pm ET

REGISTER >

Heading to the AHCA/NCAL Convention next week?Join us for our live podcast with Mark Parkinson!

AHCA promo with podcast info
PharM logo no tag - WHITE-3
Facebook
LinkedIn
X

PharMerica, 805 N. Whittington Pkwy, Louisville, KY 40222, United States

Unsubscribe Manage preferences